Header

UZH-Logo

Maintenance Infos

Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia


Stilgenbauer, Stephan; Aurran Schleinitz, Thérèse; Eichhorst, Barbara; Lang, Fabian; Offner, Fritz; Rossi, Jean-François; Schroyens, Wilfried; Van Den Neste, Eric; Ysebaert, Loïc; von Wangenheim, Ute; Ursula Kress, Uta; Blum, Petra; Zenz, Thorsten (2019). Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia. Leukemia, 33(10):2531-2535.

Statistics

Citations

Dimensions.ai Metrics
11 citations in Web of Science®
12 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

20 downloads since deposited on 10 Oct 2019
12 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Oncology and Hematology
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Hematology
Health Sciences > Oncology
Life Sciences > Cancer Research
Language:English
Date:October 2019
Deposited On:10 Oct 2019 13:53
Last Modified:29 Jul 2020 11:26
Publisher:Nature Publishing Group
ISSN:0887-6924
OA Status:Hybrid
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1038/s41375-019-0475-z
PubMed ID:31089249

Download

Hybrid Open Access

Download PDF  'Phase 1 first-in-human trial of the anti-CD37 antibody BI 836826 in relapsed/refractory chronic lymphocytic leukemia'.
Preview
Content: Published Version
Filetype: PDF
Size: 250kB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)